People: Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

15 Aug 2014
Price Change (% chg)

€-1.02 (-2.79%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Schneider, Ulf 

Brief Biography

Dr. Ulf Mark Schneider has been Chairman of the Management Board of Fresenius SE & Co KGaA since May 28, 2003. Previously, he was Group Finance Director for Gehe UK PLC, a pharmaceutical wholesale and retail distributor, in Coventry, United Kingdom. Dr. Schneider has held several senior executive positions since 1989 with Gehe's majority shareholder, Franz Haniel & Cie GmbH, a diversified German multinational company. Currently, he serves on the Supervisory Boards of several Fresenius' subsidiaries, as well as Member of the Board of Directors of APP Pharmaceuticals and Inc, FHC (Holdings), Ltd. Dr. Schneider holds a Lic. oec. degree in Finance and Accounting, a Doctorate in Philosophy (Ph.D.) in Economics from Universitaet St. Gallen and a Master of Business Administration degree from Harvard University.

Basic Compensation

Total Annual Compensation, EUR Long-Term Incentive Plans, EUR All Other, EUR Fiscal Year Total, EUR
2,456,000 -- -- 2,456,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gerd Krick


Ulf Schneider


Gerhard Rupprecht


Niko Stumpfoegger


Stephan Sturm


Birgit Grund

As Of 30 Dec 2013
Search Stocks